explore -WSS

explore

author：focus 2025-08-26 23:44:06 - browse：71

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Overprescribed: High cost isn't America's only drug problem

hotspot

WSS

JPM pitch from hospitals? Revenue streams outside of patient care

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Gene therapy denied for Afghan refugee whose father aided U.S.

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Harvard scientists, with Google, unveil the most detailed brain map ever

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare Advantage overpayments discussion gets experts fired up

The high cost of giving birth even with insurance

American taxpayers paid $1.8 trillion in health care costs in 2022

Affirmative action in medical school literally saved lives

Medicare Advantage coverage denials need scrutiny, senators say

Medical leaders decry Supreme Court decision on affirmative action

U.K. decision on ALS drug has neurologists, advocates up in arms

The high cost of giving birth even with insurance

Merck to acquire Harpoon Therapeutics for $680 million

Wikipedia

Overprescribed: High cost isn't America's only drug problem

American taxpayers paid $1.8 trillion in health care costs in 2022

A preacher's new calling: Diversifying neuroscience research

Pancreatic cancer is often deadly, but new discoveries are raising hope

Scientists uncover potential path to treating deadly childhood tumor

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

leisure time

explore

hotspot

Wikipedia